Renal Transplant Rejection
📧 Sign up to get email alerts when something new happens for Renal Transplant Rejection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-11-14Clinical Trial Update: Calcineurin Activity in Renal Recipients [Phase 4]
Phase 4 clinical trial evaluating calcineurin activity in renal transplant recipients with rejection has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: The Effect of Rituximab on the Development of Anti-Donor Antibodies [NA]
A completed clinical trial evaluated whether rituximab affects the development of anti-donor antibodies in renal transplant rejection. Resul…
-
CLINICAL_TRIALS trial_result · 2012-02-16Clinical Trial Update: Renal Function Evaluation After Reduction of Cyclosporine A Dose in Renal Transplant Patients [Phase 3]
This Phase 3 trial evaluated renal function after reducing the dose of cyclosporine A in renal transplant recipients and has completed.
-
CLINICAL_TRIALS trial_result · 2011-03-08Clinical Trial Update: Induction Therapy With Autologous Mesenchymal Stem Cells for Kidney Allografts [NA]
Clinical trial assessing induction therapy with autologous mesenchymal stem cells for kidney allografts has completed.
-
CLINICAL_TRIALS trial_result · 2007-05-10Clinical Trial Update: Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection
This clinical trial update examines how Th1/Th2 balance and monokine responses may influence the risk of renal transplant rejection.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.